An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy

Rosa Sorrentino, Ugo De Grazia, Raffaella Buzzetti, Lorenza Nistico, Carlo Iannicola, Sandro Costanzi, Roberto Tosi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Susceptibility to IDDM is strongly associated with HLA. Some HLA allelic combinations (haplotypes) can be found in most patients, whereas other haplotypes are encountered only rarely. It has been proposed that this difference in susceptibility depends on the absence (in the DR3 and DR4 haplotypes) or the presence (in the DR2 haplotype) of Asp57 in the DQ β-chain. Data on southern European populations challenge this hypothesis because the DR2 haplotype has not been associated negatively with IDDM, as reported in northern European populations. This study on a selected panel of DR2-positive Italian IDDM patients shows that 19 of 21 (90.5%) DR2 haplotypes possess a non-Asp57 DQB allele. Moreover, the same non-Asp57 subtype has a comparatively high frequency (9/28, or 32.1%, DR2 haplotypes) also in the DR2-positive healthy Italian population. The difference between patients and control subjects is significant (P <0.0001). This is the largest series of DR2-positive patients analyzed so far. Comparison with cumulated data in various white populations shows a distinct northern European-to-southern European gradient. Toward southern Europe, the relative frequency of the non-Asp57 DR2 subtype increases. Concomitantly, the apparent protective effect of the DR2 haplotype disappears. Therefore, the observed differences in DR2-IDDM association in white populations can be explained adequately by the Asp57 hypothesis, which this study's data strongly support.

Original languageEnglish
Pages (from-to)904-908
Number of pages5
JournalDiabetes
Volume41
Issue number8
Publication statusPublished - Aug 1992

Fingerprint

Type 1 Diabetes Mellitus
Haplotypes
Italy
Population
Alleles

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Sorrentino, R., De Grazia, U., Buzzetti, R., Nistico, L., Iannicola, C., Costanzi, S., & Tosi, R. (1992). An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes, 41(8), 904-908.

An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. / Sorrentino, Rosa; De Grazia, Ugo; Buzzetti, Raffaella; Nistico, Lorenza; Iannicola, Carlo; Costanzi, Sandro; Tosi, Roberto.

In: Diabetes, Vol. 41, No. 8, 08.1992, p. 904-908.

Research output: Contribution to journalArticle

Sorrentino, R, De Grazia, U, Buzzetti, R, Nistico, L, Iannicola, C, Costanzi, S & Tosi, R 1992, 'An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy', Diabetes, vol. 41, no. 8, pp. 904-908.
Sorrentino R, De Grazia U, Buzzetti R, Nistico L, Iannicola C, Costanzi S et al. An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes. 1992 Aug;41(8):904-908.
Sorrentino, Rosa ; De Grazia, Ugo ; Buzzetti, Raffaella ; Nistico, Lorenza ; Iannicola, Carlo ; Costanzi, Sandro ; Tosi, Roberto. / An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. In: Diabetes. 1992 ; Vol. 41, No. 8. pp. 904-908.
@article{de837efae4b14816a2c9e28e0fa4ced8,
title = "An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy",
abstract = "Susceptibility to IDDM is strongly associated with HLA. Some HLA allelic combinations (haplotypes) can be found in most patients, whereas other haplotypes are encountered only rarely. It has been proposed that this difference in susceptibility depends on the absence (in the DR3 and DR4 haplotypes) or the presence (in the DR2 haplotype) of Asp57 in the DQ β-chain. Data on southern European populations challenge this hypothesis because the DR2 haplotype has not been associated negatively with IDDM, as reported in northern European populations. This study on a selected panel of DR2-positive Italian IDDM patients shows that 19 of 21 (90.5{\%}) DR2 haplotypes possess a non-Asp57 DQB allele. Moreover, the same non-Asp57 subtype has a comparatively high frequency (9/28, or 32.1{\%}, DR2 haplotypes) also in the DR2-positive healthy Italian population. The difference between patients and control subjects is significant (P <0.0001). This is the largest series of DR2-positive patients analyzed so far. Comparison with cumulated data in various white populations shows a distinct northern European-to-southern European gradient. Toward southern Europe, the relative frequency of the non-Asp57 DR2 subtype increases. Concomitantly, the apparent protective effect of the DR2 haplotype disappears. Therefore, the observed differences in DR2-IDDM association in white populations can be explained adequately by the Asp57 hypothesis, which this study's data strongly support.",
author = "Rosa Sorrentino and {De Grazia}, Ugo and Raffaella Buzzetti and Lorenza Nistico and Carlo Iannicola and Sandro Costanzi and Roberto Tosi",
year = "1992",
month = "8",
language = "English",
volume = "41",
pages = "904--908",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "8",

}

TY - JOUR

T1 - An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy

AU - Sorrentino, Rosa

AU - De Grazia, Ugo

AU - Buzzetti, Raffaella

AU - Nistico, Lorenza

AU - Iannicola, Carlo

AU - Costanzi, Sandro

AU - Tosi, Roberto

PY - 1992/8

Y1 - 1992/8

N2 - Susceptibility to IDDM is strongly associated with HLA. Some HLA allelic combinations (haplotypes) can be found in most patients, whereas other haplotypes are encountered only rarely. It has been proposed that this difference in susceptibility depends on the absence (in the DR3 and DR4 haplotypes) or the presence (in the DR2 haplotype) of Asp57 in the DQ β-chain. Data on southern European populations challenge this hypothesis because the DR2 haplotype has not been associated negatively with IDDM, as reported in northern European populations. This study on a selected panel of DR2-positive Italian IDDM patients shows that 19 of 21 (90.5%) DR2 haplotypes possess a non-Asp57 DQB allele. Moreover, the same non-Asp57 subtype has a comparatively high frequency (9/28, or 32.1%, DR2 haplotypes) also in the DR2-positive healthy Italian population. The difference between patients and control subjects is significant (P <0.0001). This is the largest series of DR2-positive patients analyzed so far. Comparison with cumulated data in various white populations shows a distinct northern European-to-southern European gradient. Toward southern Europe, the relative frequency of the non-Asp57 DR2 subtype increases. Concomitantly, the apparent protective effect of the DR2 haplotype disappears. Therefore, the observed differences in DR2-IDDM association in white populations can be explained adequately by the Asp57 hypothesis, which this study's data strongly support.

AB - Susceptibility to IDDM is strongly associated with HLA. Some HLA allelic combinations (haplotypes) can be found in most patients, whereas other haplotypes are encountered only rarely. It has been proposed that this difference in susceptibility depends on the absence (in the DR3 and DR4 haplotypes) or the presence (in the DR2 haplotype) of Asp57 in the DQ β-chain. Data on southern European populations challenge this hypothesis because the DR2 haplotype has not been associated negatively with IDDM, as reported in northern European populations. This study on a selected panel of DR2-positive Italian IDDM patients shows that 19 of 21 (90.5%) DR2 haplotypes possess a non-Asp57 DQB allele. Moreover, the same non-Asp57 subtype has a comparatively high frequency (9/28, or 32.1%, DR2 haplotypes) also in the DR2-positive healthy Italian population. The difference between patients and control subjects is significant (P <0.0001). This is the largest series of DR2-positive patients analyzed so far. Comparison with cumulated data in various white populations shows a distinct northern European-to-southern European gradient. Toward southern Europe, the relative frequency of the non-Asp57 DR2 subtype increases. Concomitantly, the apparent protective effect of the DR2 haplotype disappears. Therefore, the observed differences in DR2-IDDM association in white populations can be explained adequately by the Asp57 hypothesis, which this study's data strongly support.

UR - http://www.scopus.com/inward/record.url?scp=0026647948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026647948&partnerID=8YFLogxK

M3 - Article

C2 - 1628763

AN - SCOPUS:0026647948

VL - 41

SP - 904

EP - 908

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 8

ER -